EUVIMEDEUVIMED entdecken
Open Access

Evaluation of treatment regimens and long-term clinical outcomes in patients with isoniazid-resistant pulmonary tuberculosis: a 5-year follow-up

Ayşe Feyza Aslan, Mediha Gönenç Ortaköylü, Belma Akbaba Bağcı, Sezer Toprak

Turkish Journal of Medical Sciences · 01.01.2023 · 53 (3) · 761-770

DOI: 10.55730/1300-0144.5639 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Turkish Journal of Medical Sciences, online erschienen am 01.01.2023. Verfasst von Ayşe Feyza Aslan und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pulmonary Medicine, University of Health Sciences, Yedikule Chest Diseases and Thoracic Surgery Training and Research Hospital, İstanbu…. Hauptthemen laut MEDLINE: Tuberculosis, Pulmonary, Tuberculosis, Multidrug-Resistant. Die Arbeit wurde bisher 3-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/aim: Considering its early bactericidal activity, isoniazid (H) is an important first-line agent in tuberculosis (TB) treatment. The aim of this study was to evaluate the treatment regimens and results of H-resistant pulmonary TB patients. Materials and methods: We retrospectively evaluated treatment regimens and results of 188 H-resistant pulmonary TB patients who were treated in our center between January 2015 and December 2017. Treatment regimens applied were noted and treatment outcomes were recorded. The long-term results were evaluated.

Results

Totally 174 (92.6%) of 188 patients with H-resistant pulmonary TB achieved treatment success. Ninety-seven patients (51.6%) were cured and 77 patients (41.0%) completed treatment. Five patients (2.7%) had treatment failure. Four patients (2.1%) having treatment success relapsed during one-year follow-up. Eighteen patients (9.6%) had unfavorable outcomes, including treatment failure in five (2.7%), death in nine (4.8%), and relapse in four patients (2.1%). The treatment success rate was found to be statistically higher in group 1 (9-month regimen 2HREZ/7HRE) compared with those in group 2 (9HREZ) (97.4% vs. 85.9%; p = 0.010). Group 3 (HREZFQ) and group 1 had statistically significant favorable outcomes, compared to group 2 (group 2 vs. group 3, p = 0.048; group 1 vs. group 2, p = 0.022). Interestingly, no relapse and acquired rifampicin resistance in patients occurred who received an FQ-containing regimen.

Conclusion

Our study results show higher treatment success and positive results with the treatment regimen containing FQ and that treatment with HREZ for nine months is associated with a lower treatment success rate.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Tuberculosis, PulmonaryTuberculosis, Multidrug-ResistantHumansIsoniazidAntitubercular AgentsRetrospective StudiesFollow-Up StudiesTreatment OutcomeRecurrence

Stichwörter der Autor:innen

Fluoroquinoloneisoniazid resistancetreatmenttuberculosis

Substanzen

IsoniazidAntitubercular Agents

Autor:innen und Institutionen

  • Department of Pulmonary Medicine, University of Health Sciences, Yedikule Chest Diseases and Thoracic Surgery Training and Research Hospital, İstanbul, Turkey.
  • Department of Microbiology, University of Health Sciences, Yedikule Chest Diseases and Thoracic Surgery Training and Research Hospital, İstanbul, Turkey.

Zitieren

APA

Aslan, A. F., Ortaköylü, M. G., Bağcı, B. A., & Toprak, S. (2023). Evaluation of treatment regimens and long-term clinical outcomes in patients with isoniazid-resistant pulmonary tuberculosis: a 5-year follow-up. Turkish Journal of Medical Sciences, 53(3), 761-770. https://doi.org/10.55730/1300-0144.5639

Vancouver

Aslan AF, Ortaköylü MG, Bağcı BA, Toprak S. Evaluation of treatment regimens and long-term clinical outcomes in patients with isoniazid-resistant pulmonary tuberculosis: a 5-year follow-up. Turkish Journal of Medical Sciences. 2023;53(3):761-770. doi:10.55730/1300-0144.5639

BibTeX
@article{Aslan2023,
  author = {Aslan, Ayşe Feyza and Ortaköylü, Mediha Gönenç and Bağcı, Belma Akbaba and Toprak, Sezer},
  title = {Evaluation of treatment regimens and long-term clinical outcomes in patients with isoniazid-resistant pulmonary tuberculosis: a 5-year follow-up},
  journal = {Turkish Journal of Medical Sciences},
  year = {2023},
  volume = {53},
  number = {3},
  pages = {761--770},
  doi = {10.55730/1300-0144.5639}
}
Kostenlos starten →